Evidence map›Paper›PMID 42602565›Full record

ReviewFrontiers in oncology2026

A narrative review of

Jeongmin Lee, Seung Geun Yeo, Hye Ok Kim, Jae Min Lee, Manish Kumar Singh, Sung Soo Kim, Tong In Oh, Dong Choon Park

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeongmin Lee *Department of Medicine, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Seung Geun Yeo *Department of Medicine, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Hye Ok KimDepartment of Medicine, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Jae Min LeeClinical Research Institute, Kyung Hee University Medical Center, Seoul, Republic of Korea.
Manish Kumar SinghDepartment of Biochemistry and Molecular Biology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Sung Soo KimDepartment of Biochemistry and Molecular Biology, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Tong In OhDepartment of Biomedical Engineering, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.
Dong Choon ParkDepartment of Obstetrics and Gynecology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer is often diagnosed at an advanced stage because its early symptoms are nonspecific, and the prognosis remains poor due to frequent recurrence and the development of drug resistance even after standard treatment. This review includes 19

Indexed as

chemoresistanceepithelial-mesenchymal transitionovarian canceroxidative stressreactive oxygen species

Identifiers

PMID42602565
PMCPMC13474145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.